Table 1.
Patients, No. (%) |
|||
---|---|---|---|
Variable | Preintervention Year (2008–2009) | Intervention Year (2009–2010) | P From Heterogeneity (df) |
Patient type | .28 (2) | ||
New | 1129 (11.27) | 1184 (10.73) | |
Reengaging | 320 (3.19) | 329 (2.98) | |
Active | 8569 (85.54) | 9526 (86.29) | |
Viral loada | <.0001 (1) | ||
Undetectableb | 6160 (65.11) | 7149 (68.93) | |
Detectable | 3301 (34.89) | 3222 (31.07) | |
CD4 cell count,a cells/mm3 | .1058 (1) | ||
<350 | 3819 (40.27) | 3978 (39.14) | |
≥350 | 5665 (59.73) | 6186 (60.86) | |
Scheduled visits for care, No. | <.0001 (2) | ||
1–3 | 4518 (45.10) | 5622 (50.93) | |
4–6 | 3761 (37.54) | 3818 (34.59) | |
≥7 | 1739 (17.36) | 1599 (14.49) | |
Sex | .77 (1) | ||
Male | 6520 (65.34) | 7166 (65.15) | |
Female | 3459 (34.66) | 3834 (34.85) | |
Age group, years | .0035 (3) | ||
16–29 | 561 (5.6) | 683 (6.19) | |
30–39 | 1768 (17.65) | 1861 (16.86) | |
40–49 | 3790 (37.84) | 3992 (36.16) | |
50–85 | 3898 (38.91) | 4503 (40.79) | |
Race/ethnicity | .608 (3) | ||
Black | 6370 (63.59) | 7095 (64.27) | |
White | 1676 (16.73) | 1776 (16.09) | |
Other race | 132 (1.32) | 151 (1.37) | |
Hispanic | 1840 (18.37) | 2017 (18.27) | |
HIV risk group | .259 (4) | ||
MSM | 2771 (27.66) | 3042 (27.56) | |
MSM plus IDUs | 243 (2.43) | 244 (2.21) | |
Otherc | 771 (7.70) | 891 (8.07) | |
Heterosexuals | 4893 (48.84) | 5475 (49.60) | |
IDUs | 1340 (13.38) | 1387 (12.56) | |
Clinic site | .593 (5) | ||
A | 1034 (10.32) | 1102 (9.98) | |
B | 960 (9.58) | 1017 (9.21) | |
C | 1938 (19.35) | 2130 (19.20) | |
D | 1949 (19.45) | 2108 (19.10) | |
E | 1253 (12.51) | 1448 (13.12) | |
F | 2884 (28.79) | 3234 (29.30) | |
Insurance | .0086 (3) | ||
Private | 1696 (17.05) | 1862 (16.92) | |
Medicare | 2178 (21.89) | 2269 (20.62) | |
Medicaid | 3206 (32.23) | 3479 (31.62) | |
Other/RW/noned | 2868 (28.83) | 3393 (30.84) |
Abbreviations: HIV, human immunodeficiency virus; IDUs, injection drug users; MSM, men who have sex with men; RW, Ryan White coverage
a Based on clinical records no more than ±99 days from anchor visit in preintervention and intervention periods.
b Undetectable viral loads were defined as HIV RNA levels ≤400 copies/mL.
c “Other” category includes other risk factors, unknown or undetermined risk factors, no risk factors identified, and missing data.
d For insurance, “other” includes university and local charity programs.